Source: Bone Marrow Transplantation. Unidade: FM
Assunto: TRANSPLANTE DE MEDULA ÓSSEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DULLEY, Frederico Luiz et al. Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients to allogeneic bone marrow tranplantation to reduce rejection. Bone Marrow Transplantation, v. 32, n. 7, p. 9-13, 2003Tradução . . Disponível em: https://doi.org/10.1038/sj.bmt.1704325. Acesso em: 03 maio 2024.APA
Dulley, F. L., Vigorito, A. C., Sturara, D., Ruiz, M. A., Saboya, R., Macedo, M. C. M. A., et al. (2003). Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients to allogeneic bone marrow tranplantation to reduce rejection. Bone Marrow Transplantation, 32( 7), 9-13. doi:10.1038/sj.bmt.1704325NLM
Dulley FL, Vigorito AC, Sturara D, Ruiz MA, Saboya R, Macedo MCMA, Silva RL da, Chamone D de AF, Mehta J, Bacigalupo A, Souza CA. Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients to allogeneic bone marrow tranplantation to reduce rejection [Internet]. Bone Marrow Transplantation. 2003 ; 32( 7): 9-13.[citado 2024 maio 03 ] Available from: https://doi.org/10.1038/sj.bmt.1704325Vancouver
Dulley FL, Vigorito AC, Sturara D, Ruiz MA, Saboya R, Macedo MCMA, Silva RL da, Chamone D de AF, Mehta J, Bacigalupo A, Souza CA. Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients to allogeneic bone marrow tranplantation to reduce rejection [Internet]. Bone Marrow Transplantation. 2003 ; 32( 7): 9-13.[citado 2024 maio 03 ] Available from: https://doi.org/10.1038/sj.bmt.1704325
